FDA, Health Canada and MHRA GCP and Pharmacovigilance Symposium 2024 Perspectives

In February 2024, key stakeholders from the pharmaceutical industry converged at the FDA, Health Canada, and MHRA GCP and Pharmacovigilance Symposium to discuss and learn about the latest advancements, regulatory updates, and insights shaping the future of drug safety regulation and clinical practices.

From Data Integrity and Computer System Validation to technological innovations and patient-centric approaches, our Senior Associate, Nicole Ainsworth, has summarised the key themes and takeaways from each day.

To read Nicole’s take on the symposium, click here.